Ticker	Volume	Price	Price Delta
DJIA	15,354.40	+121.18	0.80%
S&P 500	1,667.47	+17.00	1.03%
Nasdaq	3,498.97	+33.72	0.97%

Ticker

Volume

Price

Price Delta

DJIA

15,354.40

+121.18

0.80%

S&P 500

1,667.47

+17.00

1.03%

Nasdaq

3,498.97

+33.72

0.97%

Ticker	Volume	Price	Price Delta
STOXX 50	2,817.99	+11.29	0.40%
FTSE 100	6,723.06	+35.26	0.53%
DAX	8,398.00	+28.13	0.34%

Ticker

Volume

Price

Price Delta

STOXX 50

2,817.99

+11.29

0.40%

FTSE 100

6,723.06

+35.26

0.53%

DAX

8,398.00

+28.13

0.34%

Ticker	Volume	Price	Price Delta
Nikkei	15,138.10	+100.88	0.67%
Hang Seng	23,082.70	+38.44	0.17%
S&P/ASX 200	5,180.77	+15.11	0.29%

Ticker

Volume

Price

Price Delta

Nikkei

15,138.10

+100.88

0.67%

Hang Seng

23,082.70

+38.44

0.17%

S&P/ASX 200

5,180.77

+15.11

0.29%

Generic Lipitor Supply Adequate as Ranbaxy Recalls Pills

By Drew Armstrong - 2012-11-29T19:45:51Z

Ranbaxy Laboratories Ltd. (RBXY)’s recall and production halt of its version of the cholesterol pill Lipitor won’t create a supply shortage, U.S. regulators said.

Ranbaxy has stopped making the generic pills while it investigates how glass particles got into the product, the Food and Drug Administration said today in a statement. The company, based near New Delhi, announced Nov. 23 it had recalled the medicine. The FDA said it hasn’t received any reports of patients being harmed.

To contact the reporter on this story: Drew Armstrong in New York at darmstrong17@bloomberg.net;

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

More News:

Science

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.